The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Frequency of genetic homologous recombination (HR) alterations in metastatic cutaneous melanoma.
 
Kevin Kim
Honoraria - Bristol-Myers Squibb; Merck; Novartis
Consulting or Advisory Role - Foundation Medicine; Genentech
Speakers' Bureau - Bristol-Myers Squibb; Merck; Novartis
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Immune Design (Inst); Merck (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Merck
 
Stanley P. L. Leong
No Relationships to Disclose
 
Mark I. Singer
No Relationships to Disclose
 
Brian M Parrett
No Relationships to Disclose
 
John Moretto
No Relationships to Disclose
 
David R. Minor
Stock and Other Ownership Interests - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb; Merck
Consulting or Advisory Role - Theravance
Speakers' Bureau - Bristol-Myers Squibb; Merck
 
Elham Vosoughi
No Relationships to Disclose
 
Sherri Z. Millis
Employment - Foundation Medicine
 
Jeffrey S. Ross
Employment - Foundation Medicine
Leadership - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
Honoraria - EMD Serono; Pfizer
Research Funding - Foundation Medicine
 
Mohammed Kashani-Sabet
Stock and Other Ownership Interests - Melanoma Diagnostics, Inc.
Consulting or Advisory Role - Castle Biosciences
Research Funding - Merck; Merck (Inst)